Lockton Re’s proprietary analytics platform SAGE receives another US patent

lockton re logo

Lockton Re’s proprietary analytics platform SAGE has been awarded another U.S. patent covering systems and methods for customized and real-time visualization, comparison and analysis of insurance and reinsurance structures, with additional patents pending.

Key features of the platform enable customers to make faster, more informed decisions, providing greater transparency and efficiency.

By turning data into real-time financial results for risk transfer decisions, the platform allows clients to visualize, design and modify different structures to help optimize risk portfolios.

It is built on a modern stack with a future-proof framework and has and will continue to contribute to the growth of the entire market.

Driven by innovation, Lockton Re has been awarded three U.S. patents over the past three years. The reinsurer hopes this trend will continue as it advances a raft of additional patents in the pending stage.

Adam Troyer, global head of analytics at Lockton Re, commented: “SAGE by Lockton Re was inspired by our customers’ desire for better analytics to support smarter risk transfer decisions. This unique software optimizes efficient decision-making, providing flexibility, insights and economic benefits to our customers.”

Claude Yoder, chief digital officer at Lockton, added: “Analytics has been at the heart of Lockton Re’s value since its founding in 2019, and Lockton Re’s SAGE has been at the forefront of what is possible. As data and analytics become increasingly important in the reinsurance industry, Lockton Re’s SAGE platform stands out in supporting its clients.

“Securing our latest U.S. software patent is a testament to the pioneering spirit of our global analytics team and our autonomy as an independent organization. Our independence allows us to prioritize digital initiatives that deliver the most significant returns for our clients, something traditional organizations cannot match.”

Spread the love
See also  Verisk withdraws from AccuLynx acquisition

Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page